Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer.
Nucl Med Mol Imaging
; 48(1): 16-25, 2014 Mar.
Article
in En
| MEDLINE
| ID: mdl-24900134
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Nucl Med Mol Imaging
Year:
2014
Document type:
Article
Country of publication:
Alemania